LANXESS Crecimiento futuro
Future controles de criterios 0/6
Se prevé un crecimiento anual de los beneficios y los ingresos de LANXESS de 63.3% y 3.5% por año respectivamente. Se prevé que el BPA crezca en un 62.5% al año. Se espera que la rentabilidad financiera sea de -1.5% en 3 años.
Información clave
63.3%
Tasa de crecimiento de los beneficios
62.51%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Chemicals | 42.9% |
| Tasa de crecimiento de los ingresos | 3.5% |
| Rentabilidad financiera futura | -1.54% |
| Cobertura de analistas | Good |
| Última actualización | 08 May 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Artículo de análisis • May 09
Here's What Analysts Are Forecasting For LANXESS Aktiengesellschaft (ETR:LXS) After Its First-Quarter Results
LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders are probably feeling a little disappointed, since its shares fell...
Actualización de narrativa • May 01
LXS: Mixed Bank Ratings Will Drive Bullish Repricing On Higher Future P/E
Analysts have adjusted the price target on LANXESS from about €28.86 to about €26.29. This reflects updated views on faster revenue growth, much thinner profit margins, and a much higher assumed future P/E multiple after recent mixed rating changes from major banks.
Actualización de narrativa • Apr 16
LXS: Future Earnings Multiples Will Balance Mixed Ratings And Margin Execution Risk
LANXESS' updated analyst price target edges up to about €17.91 from roughly €17.81, as analysts factor in slightly higher assumed revenue growth and a marginally richer future P/E, partly offset by a more cautious profit margin view following mixed recent rating changes. Analyst Commentary Recent research views on LANXESS are mixed, with both upgrades and a downgrade pointing to different expectations around execution, earnings power and valuation risk.Actualización de narrativa • Apr 02
LXS: Future Earnings Multiples Will Reflect Mixed Rating Shifts And Execution Risk
Analysts have trimmed the LANXESS price target from about €18.66 to around €17.81, reflecting mixed recent research that balances reduced fair value and profit margin assumptions with updated views on growth and valuation following both target cuts and rating changes across the Street. Analyst Commentary Recent research on LANXESS shows a split tape, with some firms turning more positive on the shares while others are taking a more cautious line on execution and fair value assumptions.
Actualización de narrativa • Mar 19
LXS: Fair Outlook Balances Higher Risk Assumptions With Recent Upgrade
Analysts have trimmed their fair value estimate for LANXESS from €17.0 to €14.0, reflecting recent price target cuts such as Deutsche Bank's move to €17 and updated assumptions for growth, margins and risk, even as some research, including a recent Goldman Sachs upgrade, highlights potential longer term upside drivers. Analyst Commentary Recent research shows a split view on LANXESS, with some highlighting possible longer term drivers while others are reining in expectations.Actualización de narrativa • Mar 05
LXS: Upgrade And Reset Expectations Will Drive Bullish Repricing Potential
Analysts have adjusted their price targets on LANXESS, with the latest change lowering one view from €18.50 to €17. This reflects updated assumptions around discount rates, modest revenue growth and expected P/E levels.Actualización de narrativa • Feb 18
LXS: Upgrade And Margin Execution Are Expected To Drive Bullish Repricing
LANXESS's consensus analyst price target has moved modestly lower, with recent cuts to €17 and €15 cited by analysts who point to updated assumptions around discount rates, profit margins, and forward P/E expectations. Analyst Commentary Recent research on LANXESS highlights a mix of caution and optimism, with some bullish analysts focusing on potential upside if the company can execute against current expectations on margins and earnings quality.Actualización de narrativa • Feb 04
LXS: Sector Headwinds And Execution Discipline Will Drive Future Bullish Repricing
Analysts have trimmed their price expectations for LANXESS, reflected in a slightly lower fair value estimate of about €28.87 from €29.24. They cite a series of reduced Street price targets and more cautious sector views, even as underlying model assumptions such as revenue growth, profit margin and future P/E remain broadly consistent.Actualización de narrativa • Jan 21
LXS: Future Earnings Multiples Will Reward Execution Despite Sector Downgrades
Our fair value estimate for LANXESS has been reduced from about €20.30 to roughly €18.66, reflecting a cluster of lower price targets and more cautious views from analysts who now generally expect lower growth and apply a slightly higher required return. Analyst Commentary Recent Street research around LANXESS has tilted more cautious, with several firms trimming price targets and highlighting sector headwinds in European chemicals and ingredients.Actualización de narrativa • Jan 06
LXS: Earnings Resilience And Portfolio Actions Will Drive Bullish Repricing
Narrative Update The updated analyst price target framework for LANXESS points to a fair value adjustment from €31.85 to €29.24. This reflects recent target cuts from €21 to €15 at JPMorgan, a downgrade to Underweight with a €15 target at Barclays, and a reduction from €26 to €23 at Citi that collectively signal increased caution among analysts.Artículo de análisis • Jan 02
A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Key Insights The projected fair value for LANXESS is €14.85 based on 2 Stage Free Cash Flow to Equity LANXESS' €17.62...Actualización de narrativa • Dec 17
LXS: Demand Recovery And Margin Actions Will Drive Bullish Repricing
Analysts have trimmed their price target on LANXESS to EUR 15 from EUR 21, citing weaker expected revenue growth, lower profit margins, a higher discount rate, and a richer future P E multiple. Together, these factors reduce estimated fair value from about EUR 37.49 to EUR 31.85 per share.Artículo de análisis • Dec 15
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Actualización de narrativa • Dec 03
LXS: Future Earnings Multiples Will Reward Improving Execution Amid Sector Caution
The analyst fair value estimate for LANXESS has been reduced slightly to EUR 20.30 from EUR 20.92, as analysts factor in lower sector sentiment, a modestly softer revenue growth outlook, and recent cuts to Street price targets across the European chemicals space. Analyst Commentary Street research on LANXESS has turned more cautious, with recent revisions reflecting concerns around sector headwinds, execution risk, and a less supportive valuation backdrop.Actualización de narrativa • Nov 19
LXS: Future Earnings Multiples Will Reflect Sector Caution And Resilient Performance
LANXESS’s analyst price target has been revised downward from €24.55 to €20.92 as analysts cite sector-wide caution and a reassessment of fair value within the European chemicals industry. Analyst Commentary The recent series of updates from street research highlights both supportive and cautious sentiment regarding LANXESS’s outlook, reflecting the evolving landscape in the European chemicals sector.Actualización de narrativa • Nov 05
LXS: Future Resilience Will Support Stability Amid Sector Pressures
Analysts have modestly reduced their price target for LANXESS by approximately EUR 0.30. This adjustment reflects more cautious growth and valuation assumptions in light of recent sector performance and peer comparisons.Actualización de narrativa • Oct 22
Analysts Lower LANXESS Price Target and Ratings Amid Mixed Outlook and Valuation Shifts
The analyst price target for LANXESS has been reduced by approximately EUR 0.67 to EUR 24.85. This change reflects revised expectations on revenue growth and profitability as analysts adjust their outlook in light of recent performance and updated industry assessments.Actualización de narrativa • Oct 08
Portfolio Optimization And Sustainable Initiatives Will Unlock Market Opportunities
The analyst consensus price target for LANXESS has been reduced from €26.79 to €25.52. Analysts cite increased caution due to reduced expected growth and valuation concerns following the company's recent outperformance among peers.Actualización de narrativa • Aug 29
Accelerated FORWARD! Program Set To Improve Future Performance
Analysts have lowered LANXESS's price target to €26.79, citing ongoing operational headwinds, margin pressure, and delayed recovery in key markets, while acknowledging that cost measures will take time to improve earnings. Analyst Commentary Bearish analysts cite persistent near-term operational headwinds and sluggish demand as reasons for lowering price targets.Artículo de análisis • Jul 03
Is LANXESS Aktiengesellschaft (ETR:LXS) Trading At A 46% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, LANXESS fair value estimate is €47.92 LANXESS is estimated to...
Nueva narrativa • Mar 22
Accelerated FORWARD! Program Set To Improve Future Performance
Successful cost savings and portfolio transformation initiatives are boosting profitability, improving margins, and enhancing future earnings potential through strategic divestitures.Artículo de análisis • Mar 07
Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) 25% Share Price Surge
LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders have had their patience rewarded with a 25% share price jump in the...Artículo de análisis • Jan 31
LANXESS (ETR:LXS) Use Of Debt Could Be Considered Risky
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Artículo de análisis • Jan 07
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Artículo de análisis • Oct 30
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Artículo de análisis • Sep 07
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Artículo de análisis • Jul 23
Is LANXESS (ETR:LXS) Using Debt Sensibly?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Artículo de análisis • May 27
Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?
While LANXESS Aktiengesellschaft ( ETR:LXS ) might not have the largest market cap around , it saw a double-digit share...Artículo de análisis • May 08
Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) P/S
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.4x is...Artículo de análisis • Apr 20
Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 42% Undervaluation?
Key Insights The projected fair value for LANXESS is €44.32 based on 2 Stage Free Cash Flow to Equity LANXESS is...Artículo de análisis • Mar 22
Is LANXESS (ETR:LXS) Weighed On By Its Debt Load?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Artículo de análisis • Jan 27
What You Can Learn From LANXESS Aktiengesellschaft's (ETR:LXS) P/S
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Artículo de análisis • Dec 05
Is LANXESS (ETR:LXS) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • Nov 01
A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Key Insights The projected fair value for LANXESS is €20.51 based on Dividend Discount Model Current share price of...Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2028 | 6,103 | -3 | 173 | 540 | 12 |
| 12/31/2027 | 5,931 | -67 | 155 | 487 | 15 |
| 12/31/2026 | 5,857 | -210 | 71 | 361 | 10 |
| 3/31/2026 | 5,450 | -661 | 52 | 367 | N/A |
| 12/31/2025 | 5,673 | -577 | -30 | 289 | N/A |
| 9/30/2025 | 5,888 | -243 | 112 | 432 | N/A |
| 6/30/2025 | 6,148 | -165 | 112 | 441 | N/A |
| 3/31/2025 | 6,360 | -136 | 164 | 490 | N/A |
| 12/31/2024 | 6,366 | -177 | 188 | 508 | N/A |
| 9/30/2024 | 6,319 | -690 | 71 | 377 | N/A |
| 6/30/2024 | 6,322 | -822 | 407 | 708 | N/A |
| 3/31/2024 | 6,422 | -951 | 323 | 629 | N/A |
| 12/31/2023 | 6,714 | -843 | 512 | 838 | N/A |
| 9/30/2023 | 7,251 | -280 | 433 | 785 | N/A |
| 6/30/2023 | 7,835 | -65 | 32 | 414 | N/A |
| 3/31/2023 | 8,056 | 128 | 94 | 501 | N/A |
| 12/31/2022 | 8,088 | 184 | -248 | 159 | N/A |
| 9/30/2022 | 7,794 | 191 | -136 | 296 | N/A |
| 6/30/2022 | 7,190 | 147 | -60 | 372 | N/A |
| 3/31/2022 | 6,660 | 146 | -228 | 194 | N/A |
| 12/31/2021 | 6,101 | 116 | -17 | 407 | N/A |
| 9/30/2021 | 5,925 | 119 | -62 | 371 | N/A |
| 6/30/2021 | 5,805 | 105 | 7 | 444 | N/A |
| 3/31/2021 | 5,772 | 863 | 72 | 515 | N/A |
| 12/31/2020 | 6,104 | 892 | 129 | 585 | N/A |
| 9/30/2020 | 6,237 | 883 | 113 | 590 | N/A |
| 6/30/2020 | 6,480 | 938 | 185 | 677 | N/A |
| 3/31/2020 | 6,768 | 231 | 200 | 713 | N/A |
| 12/31/2019 | 6,802 | 255 | N/A | 643 | N/A |
| 9/30/2019 | 6,559 | 266 | N/A | 685 | N/A |
| 6/30/2019 | 6,641 | 243 | N/A | 665 | N/A |
| 3/31/2019 | 6,746 | 212 | N/A | 595 | N/A |
| 12/31/2018 | 6,824 | 190 | N/A | 586 | N/A |
| 9/30/2018 | 7,066 | 144 | N/A | 603 | N/A |
| 6/30/2018 | 6,990 | 138 | N/A | 737 | N/A |
| 3/31/2018 | 6,873 | 63 | N/A | 881 | N/A |
| 12/31/2017 | 6,530 | 23 | N/A | 868 | N/A |
| 9/30/2017 | 6,810 | 73 | N/A | 692 | N/A |
| 6/30/2017 | 7,021 | 83 | N/A | 627 | N/A |
| 3/31/2017 | 7,252 | 166 | N/A | 651 | N/A |
| 12/31/2016 | 7,699 | 192 | N/A | 689 | N/A |
| 9/30/2016 | 7,590 | 205 | N/A | 882 | N/A |
| 6/30/2016 | 7,622 | 184 | N/A | 768 | N/A |
| 3/31/2016 | 7,784 | 196 | N/A | 707 | N/A |
| 12/31/2015 | 7,902 | 165 | N/A | 692 | N/A |
| 9/30/2015 | 8,000 | 82 | N/A | 751 | N/A |
| 6/30/2015 | 8,087 | 76 | N/A | 762 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que LXS siga sin ser rentable en los próximos 3 años.
Beneficios vs. Mercado: Se prevé que LXS siga sin ser rentable en los próximos 3 años.
Beneficios de alto crecimiento: Se prevé que LXS siga sin ser rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (3.5% al año) de LXS crezcan más despacio que el mercado de German (7.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 3.5% al año) de LXS crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: LXS se prevé que no sea rentable en 3 años.
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/17 05:12 |
| Precio de las acciones al final del día | 2026/05/15 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
LANXESS Aktiengesellschaft está cubierta por 35 analistas. 15 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| James Knight | Barclays |
| Anil Shenoy | Barclays |
| Andres Castanos-Mollor | Berenberg |